Abstract
The authors regret the following corrigendum: After the publication of the manuscript, we realised that “dyskariosis” was used for the search in EMBASE instead of the correct spelling “dyskaryosis”. Post-hoc searches in EMBASE both for ‘cervical severe dyskariosis’ and ‘cervical severe dyskaryosis’ search strings resulted in “0” hits retrieved in both cases. Therefore, the final output was not affected by this typo. The authors would like to apologise for any inconvenience caused.
| Original language | English |
|---|---|
| Article number | 126701 |
| Journal | Vaccine |
| Volume | 47 |
| DOIs |
|
| Publication status | Published - 15 Feb 2025 |
Bibliographical note
Publisher Copyright:© 2024 GlaxoSmithKline Biologicals S.A
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Corrigendum to How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects? Vaccine. 2024 Oct 24;42(24):126215. doi: 10.1016/j.vaccine.2024.126215. Epub 2024 Aug 29. PMID: 39213982 (Vaccine (2024) 42(24), (S0264410X24008971), (10.1016/j.vaccine.2024.126215))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver